Sign in

CIK 0001819133

  • Non-accelerated filer
  • Smaller reporting company

Tango Therapeutics, Inc.

Sign in to watch
Ticker
TNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-320-4900
Business address
201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
Former names
BCTG Acquisition Corp.
  1. 4 Open-market sale General Counsel sold 2,776 shares at an average $12.59 ($34,951)
  2. 4 Open-market sale Chief Financial Officer sold 3,725 shares at an average $12.59 ($46,900)
  3. 4 Open-market sale Crystal Adam sold 8,371 shares at an average $12.59 ($105,395)
  4. 4 Grant or award Chief Financial Officer acquired 39,413 shares (grant or award)
  5. 4 Grant or award Crystal Adam acquired 46,599 shares (grant or award)
  6. 4 Grant or award Chief Executive Officer acquired 87,168 shares (grant or award)
  7. 4 Grant or award General Counsel acquired 22,859 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market sale Crystal Adam sold 7,507 shares at $8.39 ($62,994)
  10. 4/A Open-market buy Boxer Capital, LLC bought 1,250,000 shares at an average $6.98 ($8,722,500)
  11. 4 Open-market buy Boxer Capital, LLC bought 1,250,000 shares at an average $6.98 ($8,722,500)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market sale Boxer Capital, LLC sold 225,000 shares at an average $9.96 ($2,240,250)
  14. 4/A Grant or award Director acquired 475,000 shares (grant or award)
  15. 4 Grant or award Director acquired 10,000 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market buy Boxer Capital, LLC bought 475,000 shares at $5.15 ($2,446,250)
  19. 4 Grant or award Director acquired 5,000 shares (grant or award)
  20. 4 Grant or award Director acquired 5,000 shares (grant or award)

Page 5 of 8 · 156 filings